Pharmacokinetic/Pharmacodynamic Modellingof GnRH Antagonist Degarelix: A Comparisonof the Non-linear Mixed-Effects Programs NONMEM and NLME

By Tornøe Christoffer   Agersø Henrik   Nielsen Henrik   Madsen Henrik   Jonsson E.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 31, Iss. 6, 2004-12 ,pp. : 441-461

Springer Publishing Company

Access to resources Recommend Favorite

Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

By Roulier Roger   Chabert-Orsini Véronique   Sitri Marie-Christine   Barry Bernard   Terriou P  

Reproductive BioMedicine Online, Vol. 7, Iss. 2, 2003-09 ,pp. : 185-189

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Semi-Mechanistic Pharmacodynamic Modeling for Degarelix, a Novel Gonadotropin Releasing Hormone (GnRH) Blocker

By Jadhav Pravin   Agersø Henrik   Tornøe Christoffer   Gobburu Jogarao  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 5, 2006-10 ,pp. : 609-634

Springer Publishing Company

Access to resources Recommend Favorite

GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis

By Franco JG   Baruffi RLR   Mauri AL   Petersen CG   Felipe V   Cornicelli J   Cavagna M   Oliveira JBA  

Reproductive BioMedicine Online, Vol. 13, Iss. 5, 2006-11 ,pp. : 618-627

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ   Caglar GS   Sozen E   Akarsu C   Tuncay G   Ozbıcer T   Vicdan K  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite